Effect of pemafibrate in reducing intestinal long-chain fatty acid absorption and hepatic fibrosis in metabolic dysfunction-associated steatohepatitis rats
Pemafibrate reduced lipid droplet formation and LCFA absorption in the intestinal tract and alleviated hepatic fibrosis in MASH model rats.
Authors
- Yasunori Yamamoto (ORCID: https://orcid.org/0000-0003-4160-9608)
- Yoichi Hiasa (ORCID: https://orcid.org/0000-0003-4117-339X)
- Teruki Miyake (ORCID: https://orcid.org/0000-0002-9905-5356)
- Masakazu Hanayama (ORCID: https://orcid.org/0000-0002-9805-0123)
- Eiji Takeshita (ORCID: https://orcid.org/0000-0002-9344-1264)
- Masaya Okada
- Yoshio Ikeda (ORCID: https://orcid.org/0000-0001-8244-8703)
- Osamu Yoshida (ORCID: https://orcid.org/0000-0002-5015-0045)
Institutions
- Matsuyama Shimin Hospital (JP)
- Ehime University Hospital (JP)
- Ehime University (JP)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1186/s12876-025-03967-z
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Kowa Company